{"title":"Percutaneous Electrolysis in Patients with Musculoskeletal Disorders: A Systematic Review","authors":"S. Varela-Rodríguez, Caceres-Pajuelo Je, S. Jl","doi":"10.37421/1747-0862.2021.15.476","DOIUrl":null,"url":null,"abstract":"Background: Musculoskeletal disorders are a leading cause of disability and loss of quality of life with a great economic impact. Percutaneous electrolysis is a minimally invasive technique with emerging evidence related to these pathologies. Objective: To examine the effectiveness of percutaneous electrolysis for musculoskeletal pain. Methods: A randomized clinical trials concerning percutaneous electrolysis were searched in the following electronic databases: PubMed, PEDro, CINAHL, MEDLINE, Scopus, Web of Science, Cochrane Library and ScienceDirect. Methodological quality was evaluated according to PEDro score. Risk of bias assessment was conducted using the Cochrane RoB 2 tool. These procedures were carried out by two independent researchers, with the participation of a third reviewer in case of disagreement. Results: Electronic databases searches identified a total of 175 results. After the study selection procedure, 7 studies published from 2015 to 2018 were finally included in the present review. These articles involved a total of 407 patients with different musculoskeletal disorders. Clinical outcomes were evaluated for pain and disability, usually reporting greater improvements in the group with percutaneous electrolysis. The mean score of PEDro scale was 7 points and overall risk of bias was generally reported as high. Conclusion: Percutaneous electrolysis appears to be an effective therapy for the improvement of pain and disability in patients with musculoskeletal disorders. However, the heterogeneity and the high risk of bias of the included studies should be taken into account. Further research is warranted to standardise percutaneous electrolysis application and generate protocols that would improve clinical outcomes.","PeriodicalId":88269,"journal":{"name":"Journal of molecular and genetic medicine : an international journal of biomedical research","volume":"15 1","pages":"1-7"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of molecular and genetic medicine : an international journal of biomedical research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37421/1747-0862.2021.15.476","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4
Abstract
Background: Musculoskeletal disorders are a leading cause of disability and loss of quality of life with a great economic impact. Percutaneous electrolysis is a minimally invasive technique with emerging evidence related to these pathologies. Objective: To examine the effectiveness of percutaneous electrolysis for musculoskeletal pain. Methods: A randomized clinical trials concerning percutaneous electrolysis were searched in the following electronic databases: PubMed, PEDro, CINAHL, MEDLINE, Scopus, Web of Science, Cochrane Library and ScienceDirect. Methodological quality was evaluated according to PEDro score. Risk of bias assessment was conducted using the Cochrane RoB 2 tool. These procedures were carried out by two independent researchers, with the participation of a third reviewer in case of disagreement. Results: Electronic databases searches identified a total of 175 results. After the study selection procedure, 7 studies published from 2015 to 2018 were finally included in the present review. These articles involved a total of 407 patients with different musculoskeletal disorders. Clinical outcomes were evaluated for pain and disability, usually reporting greater improvements in the group with percutaneous electrolysis. The mean score of PEDro scale was 7 points and overall risk of bias was generally reported as high. Conclusion: Percutaneous electrolysis appears to be an effective therapy for the improvement of pain and disability in patients with musculoskeletal disorders. However, the heterogeneity and the high risk of bias of the included studies should be taken into account. Further research is warranted to standardise percutaneous electrolysis application and generate protocols that would improve clinical outcomes.
背景:肌肉骨骼疾病是导致残疾和生活质量下降的主要原因,具有巨大的经济影响。经皮电解是一种微创技术,与这些病理相关的证据越来越多。目的:探讨经皮电解法治疗骨骼肌疼痛的疗效。方法:在PubMed、PEDro、CINAHL、MEDLINE、Scopus、Web of Science、Cochrane Library和ScienceDirect等电子数据库中检索与经皮电解相关的随机临床试验。根据PEDro评分评价方法学质量。偏倚风险评估采用Cochrane RoB 2工具进行。这些程序由两名独立的研究人员进行,如果有不同意见,第三位审稿人也会参与。结果:电子数据库检索共鉴定出175个结果。经过研究选择程序,2015年至2018年发表的7项研究最终纳入本综述。这些文章共涉及407名患有不同肌肉骨骼疾病的患者。临床结果评估疼痛和残疾,通常报告经皮电解组有较大改善。PEDro量表的平均得分为7分,总体偏倚风险普遍较高。结论:经皮电解法是改善肌肉骨骼疾病患者疼痛和残疾的有效方法。然而,应考虑纳入研究的异质性和高偏倚风险。进一步的研究是必要的,以规范经皮电解应用和制定方案,将改善临床结果。